Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study

被引:9
作者
Chidambaram, Swathikan [1 ]
Owen, Richard [2 ,3 ]
Sgromo, Bruno [2 ]
Chmura, Magdalena [2 ]
Kisiel, Aaron [4 ]
Evans, Richard [4 ]
Griffiths, Ewen A. [4 ]
Castoro, Carlo [5 ]
Gronnier, Caroline [6 ]
Maoawyes, Mometo Ali [7 ]
Gutschow, Christian A. [7 ]
Piessen, Guillaume [8 ]
Degisors, Sebastien [8 ]
Alvieri, Rita [9 ]
Feldman, Hope [10 ]
Capovilla, Giovanni [11 ]
Grimminger, Peter P. [11 ]
Han, Shiwei [12 ,13 ]
Low, Donald E. [12 ,13 ]
Moore, Jonathan [14 ]
Gossage, James [14 ]
Voeten, Dan [15 ]
Gisbertz, Suzanne S. [15 ]
Ruurda, Jelle [16 ]
van Hillegersberg, Richard [16 ]
D'Journo, Xavier B. [17 ]
Chmelo, Jakub [18 ]
Phillips, Alexander W. [18 ]
Rosati, Riccardo [19 ]
Hanna, George B. [1 ]
Maynard, Nick [2 ]
Hofstetter, Wayne [10 ]
Ferri, Lorenzo [20 ]
Berge Henegouwen, Mark I. [15 ]
Markar, Sheraz R. [2 ,21 ]
机构
[1] Imperial Coll London, St Marys Hosp, Dept Surg & Canc, Acad Surg Unit, London, England
[2] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Surg, Oxford, England
[3] Univ Oxford, Ludwig Inst Canc Res, Oxford, England
[4] Birmingham Univ Hosp NHS Fdn Trust, Queen Elizabeth Hosp, Dept Surg, Birmingham, England
[5] Humanitas Res Hosp, Gen Gastr & Esophagus Surg Unit, Rozzano, Italy
[6] CHU Bordeaux, Ctr Magellan, Digest Surg Dept, Esophageal & Endocrine Surg Unit, Bordeaux, France
[7] Univ Hosp Zurich, Comprehens Canc Ctr, Stomach & Oesophageal Tumor Ctr, Zurich, Switzerland
[8] Univ Hosp Claude Huriez, Dept Digest & Gen Surg, Cedex, Lille, France
[9] IOV IRCCS, Veneto Inst Oncol, Oncol Surg Unit, Padua, Italy
[10] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
[11] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Surg, Mainz, Germany
[12] Virginia Mason Hosp, Dept Thorac Surg & Thorac Oncol, Seattle, WA USA
[13] Seattle Med Ctr, Seattle, WA USA
[14] Guys & St Thomas Hosp NHS Fdn Trust, Dept Surg, London, England
[15] Univ Amsterdam, Canc Ctr Amsterdam, Dept Surg, Amsterdam UMC, Amsterdam, Netherlands
[16] Univ Med Ctr, Dept Upper Gastrointestinal Surg, Utrecht, Netherlands
[17] North Hosp, Dept Thorac Surg Dis Esophagus & Lung Transplantat, Chemin Bourrely, Marseille, France
[18] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Northern Esophagogastr Unit, Newcastle Upon Tyne, England
[19] Osped San Raffaele, Dept GI Surg, Milan, Italy
[20] McGill Univ, Montreal Gen Hosp, Dept Surg & Oncol, Montreal, PQ, Canada
[21] Univ Oxford, Nuffield Dept Surg, Oxford, England
关键词
chemoradiotherapy; esophageal cancer; esophagectomy; salvage esophagectomy; PHASE-III TRIAL; RADIATION-THERAPY; SURGERY; CHEMORADIATION; RADIOTHERAPY; MORBIDITY; MORTALITY; SURVIVAL; OUTCOMES;
D O I
10.1097/SLA.0000000000006028
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To determine the impact of delayed surgical intervention following chemoradiotherapy (CRT) on survival from esophageal cancer.Background: CRT is a core component of multimodality treatment for locally advanced esophageal cancer. The timing of surgery following CRT may influence the probability of performing an oncological resection and the associated operative morbidity.Methods: This was an international, multicenter, cohort study, including patients from 17 centers who received CRT followed by surgery between 2010 and 2020. In the main analysis, patients were divided into 4 groups based upon the interval between CRT and surgery (0-50, 51-100, 101-200, and >200 days) to assess the impact upon 90-day mortality and 5-year overall survival. Multivariable logistic and Cox regression provided hazard ratios (HRs) with 95% CIs adjusted for relevant patient, oncological, and pathologic confounding factors.Results: A total of 2867 patients who underwent esophagectomy after CRT were included. After adjustment for relevant confounders, prolonged interval following CRT was associated with an increased 90-day mortality compared with 0 to 50 days (reference): 51 to 100 days (HR=1.54, 95% CI: 1.04-2.29), 101 to 200 days (HR=2.14, 95% CI: 1.37-3.35), and >200 days (HR=3.06, 95% CI: 1.64-5.69). Similarly, a poorer 5-year overall survival was also observed with prolonged interval following CRT compared with 0 to 50 days (reference): 101 to 200 days (HR=1.41, 95% CI: 1.17-1.70), and >200 days (HR=1.64, 95% CI: 1.24-2.17).Conclusions: Prolonged interval following CRT before esophagectomy is associated with increased 90-day mortality and poorer long-term survival. Further investigation is needed to understand the mechanism that underpins these adverse outcomes observed with a prolonged interval to surgery.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 50 条
  • [11] Outcomes from chemoradiotherapy for patients with esophageal cancer
    Pantling, A. Z.
    Gossage, J. A.
    Mamidanna, R.
    Newman, G.
    Robinson, A.
    Manifold, D. K.
    Hale, P. C.
    DISEASES OF THE ESOPHAGUS, 2011, 24 (03) : 172 - 176
  • [12] Preoperative neutrophil-to-lymphocyte ratio after chemoradiotherapy for esophageal squamous cell carcinoma associates with postoperative pulmonary complications following radical esophagectomy
    Lo, Chien-Ming
    Lu, Hung-I.
    Wang, Yu-Ming
    Chen, Yen-Hao
    Chen, Yu
    Chen, Li-Chun
    Li, Shau-Hsuan
    PERIOPERATIVE MEDICINE, 2024, 13 (01)
  • [13] Esophageal cancer: definitive chemoradiotherapy for elderly patients
    Wakui, R.
    Yamashita, H.
    Okuma, K.
    Kobayashi, S.
    Shiraishi, K.
    Terahara, A.
    Sasano, N.
    Ohtomo, K.
    Nakagawa, K.
    DISEASES OF THE ESOPHAGUS, 2010, 23 (07): : 572 - 579
  • [14] Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer
    Hamai, Y.
    Hihara, J.
    Taomoto, J.
    Yamakita, I.
    Ibuki, Y.
    Okada, M.
    DISEASES OF THE ESOPHAGUS, 2015, 28 (04) : 358 - 364
  • [15] Survival and complications after neoadjuvant chemotherapy or chemoradiotherapy for esophageal cancer: a meta-analysis
    Han, Jinmin
    Wang, Zhongtang
    Liu, Chengxin
    FUTURE ONCOLOGY, 2021, 17 (17) : 2257 - 2274
  • [16] Impact of Postoperative Radiation after Esophagectomy for Esophageal Cancer
    Schreiber, David
    Rineer, Justin
    Vongtama, Dan
    Wortham, Angela
    Han, Peter
    Schwartz, David
    Choi, Kwang
    Rotman, Marvin
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (02) : 244 - 250
  • [17] Primary lung cancer surgery after curative chemoradiotherapy for esophageal cancer patients
    Shien, Kazuhiko
    Yamashita, Motohiro
    Okazaki, Mikio
    Suehisa, Hiroshi
    Sawada, Shigeki
    Miyoshi, Shinichiro
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2011, 12 (06) : 1002 - 1006
  • [18] Treatment Outcomes and Risk Factors for Incomplete Treatment after Definitive Chemoradiotherapy for Non-Resectable or Metastatic Esophageal Cancer
    Pai, Chu-Pin
    Chien, Ling-, I
    Huang, Chien-Sheng
    Hsu, Han-Shui
    Hsu, Po-Kuei
    CANCERS, 2023, 15 (22)
  • [19] Risk Factors for Tumor Positive Resection Margins After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Results From the Dutch Upper GI Cancer Audit A Nationwide Population-Based Study
    Defize, Ingmar L.
    Goense, Lucas
    Borggreve, Alicia S.
    Mook, Stella
    Meijer, Gert J.
    Ruurda, Jelle P.
    van Hillegersberg, Richard
    Dutch Upper GI Canc Audit Grp
    ANNALS OF SURGERY, 2023, 277 (02) : E313 - E319
  • [20] Preoperative Chemoradiotherapy for Esophageal Cancer: Factors Associated with Clinical Response and Postoperative Complications
    Morita, Masaru
    Masuda, Takanobu
    Okada, Satoko
    Yoshinaga, Keiji
    Saeki, Hiroshi
    Tokunaga, Eriko
    Endo, Kazuya
    Emi, Yasunori
    Kakeji, Yoshihiro
    Maehara, Yoshihiko
    ANTICANCER RESEARCH, 2009, 29 (07) : 2555 - 2562